Microbial transglutaminase is immunogenic and potentially pathogenic in pediatric celiac disease

Frontiers in Pediatrics

Volumn 6, Issue , 2018, Pages

  Torsten, Matthias ^a   Aaron, Lerner ^a,b  

^a Aesku Kipp Institute   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Celiac disease; Cross linking; Food additive; Gluten; Microbial transglutaminase; Microbiome

Indexed keywords

EID: 85059783904     PISSN: None     EISSN: 22962360     Source Type: Journal    
DOI: 10.3389/fped.2018.00389     Document Type: Review

References (69)

1. Hardy MY, Tye-Din JA. Coeliac disease: a unique model for investigating broken tolerance in autoimmunity. Clin Transl Immunol. (2016) 5:e112. doi: 10.1038/cti.2016.58
2. Parzanese I, Qehajaj D, Patrinicola F, AralicaM, Chiriva-InternatiM, Stifter S, et al. Celiac disease: from pathophysiology to treatment. World J Gastrointest Pathophysiol. (2017) 8:27-38. doi: 10.4291/wjgp.v8.i2.27
3. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet (2018) 391:70-81. doi: 10.1016/S0140-6736(17)31796-8
4. Lerner A, ArleevskayaM, Schmiedl A, Matthias T. Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes? Front Microbiol. (2017) 8:1392. doi: 10.3389/fmicb.2017.01392
5. Lionetti E, Catassi C. The role of environmental factors in the development of celiac disease: what is new? Diseases (2015) 3:282-93. doi: 10.3390/diseases3040282
6. Lerner A, Jeremias P, Matthias T. The world incidence of celiac disease is increasing: a review. Int J Recent Sci Res. (2015) 7:5491-6
7. Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing: a review. Int J Celiac Dis. (2015) 3:151-5. doi: 10.12691/ijcd-3-4-8
8. Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev. (2015) 14:479-89. doi: 10.1016/j.autrev.2015.01.009
9. Lerner A,Matthias T. Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis. Nutr Rev. (2015) 73:544-52 doi: 10.1093/nutrit/nuv011
10. Lerner A, Neidhöfer S, Matthias T. Transglutaminase 2 and antitransglutaminase 2 autoantibodies in celiac disease and beyond: Part A: TG2 double-edged sword: gut and extraintestinal involvement. Immun Res. (2015) 11:101-5. doi: 10.4172/1745-7580.10000101
11. Ando H, Adachi M, Umeda K, Matsuura A, Nonaka M, Uchio, R, et al. Purification and characteristics of a novel transglutaminase derived from microorganisms. Agric Biol Chem. (1989) 53:2613-7
12. Martins IM, Matos M, Costa R, Silva F, Pascoal A, Estevinho LM, et al. Transglutaminases: recent achievements and new sources. Appl Microbiol Biotechnol. (2014) 98:6957-64. doi: 10.1007/s00253-014-5894-1
13. Lerner A, Aminov R, Matthias T. Transglutaminases in dysbiosis as potential environmental drivers of autoimmunity. Front Microbiol. (2017) 8:article 66. doi: 10.3389/fmicb.2017.00066
14. Yu J. Pian Y. Ge J, Guo J. Zheng Y. Jiang H, et al. Functional and structural characterization of the antiphagocytic properties of a novel transglutaminase from Streptococcus suis. J Biol Chem. (2015) 290:19081-92. doi: 10.1074/jbc.M115.643338
15. Rombouts I, Lamberts L, Celus I, Lagrain B, Brijs K, Delcour JA. Wheat gluten amino acid composition analysis by high-performance anionexchange chromatography with integrated pulsed amperometric detection. J Chromatogr A (2009) 1216:5557-62. doi: 10.1016/j.chroma.2009.05.066
16. Lerner A, Aminov R,Matthias T. Dysbiosis may trigger autoimmune diseases via inappropriate posttranslational modification of host proteins. Front Microbiol. (2016) 7: 84. doi: 10.3389/fmicb.2016.00084
17. Reif S, Lerner A. Tissue transglutaminase-the key player in celiac disease: a review. Autoimm Rev. (2004) 3:40-5. doi: 10.1016/S1568-9972(03)00065-X
18. Kieliszek M, Misiewicz A. Microbial transglutaminase and its application in the food industry. Rev Folia Microbiol. (2014) 59:241-50. doi: 10.1007/s12223-013-0287-x
19. Rachel NM, Pelletier JN. Biotechnological applications of transglutaminases. Biomolecules (2013) 3:870-88. doi: 10.3390/biom30 40870
20. Santhi D, Kalaikannan A,Malairaj P, Arun Prabhu S. Application of microbial transglutaminase in meat foods: a review. Crit Rev Food Sci Nutr. (2017) 57:2071-6. doi: 10.1080/10408398.2014.945990
21. Gaspar AL, de Góes-Favoni SP. Action of microbial transglutaminase (MTGase) in the modification of food proteins: a review. Food Chem. (2015) 171:315-22. doi: 10.1016/j.foodchem.2014.09.019
22. MotokiM, Seguro K. Transglutaminase and its use for food processing. Trends Food Sci Tech. (1998) 9:204-10. doi: 10.1016/S0924-2244(98)00038-7
23. Heil A, Ohsam J, Büchold C, Pasternack R, Yokoyama K, Kumazawa, Y, et al. Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope. J Cereal Sci. (2016) 70:47-56. doi: 10.1016/j.jcs.2016.05.022
24. Gerrard JA, Fayle SE, Brown PA, Sutton KH, Simmons L, Rasiah I. Effects of microbial transglutaminase on the wheat proteins of bread and croissant dough. J Food Sci. (2001) 66:782-6. doi: 10.1111/j.1365-2621.2001.tb15172.x
25. Yokoyama K, Nio N, Kikuchi Y. Properties and applications of microbial transglutaminase. Appl Microbiol Biotechnol. (2004) 64:447-54. doi: 10.1007/s00253-003-1539-5
26. Malandain H. Transglutaminases: a meeting point for wheat allergy, celiac disease, and food safety Europ. Ann Aller Clin Immun. (2005) 37:397-403
27. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol. (2005) 3:431-8. doi: 10.1038/nrmicro1152
28. Bruce SE, Bjarnason I, Peters TJ. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci. (1985) 68:573-9. doi: 10.1042/cs0680573
29. Lerner A, Aminov R, Matthias T. Horizontal gene transfer in the human gut. Front Immunol. (2017) 8:1630. doi: 10.3389/fimmu.2017.01630
30. Devirgiliis C, Zinno P, Perozzi G. Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species. Front Microbiol. (2013) 4:301. doi: 10.3389/fmicb.2013.00301
31. Flórez AB, Campedelli I, Delgado S, Alegría á, Salvetti E, Felis GE, et al. Antibiotic susceptibility profiles of dairy leuconostoc, analysis of the genetic basis of atypical resistances and transfer of genes in vitro and in a food matrix. PLoS ONE (2016) 11:e0145203. doi: 10.1371/journal.pone.0145203
32. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. (2008) 74:6032-40. doi: 10.1128/AEM.00991-08
33. Egervärn M, Lindmark H, Olsson J, Roos S. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie Van Leeuwenhoek (2010) 97:189-200. doi: 10.1007/s10482-009-9401-0
34. Tajkarimi M, Wexler HM. CRISPR-Cas systems in Bacteroides fragilis, an important pathobiont in the human gut microbiome. Front Microbiol. (2017) 8:2234. doi: 10.3389/fmicb.2017.02234
35. Zhou ZC, Zheng J, Wei YY, Chen T, Dahlgren RA, Shang X, et al. Antibiotic resistance genes in an urban river as impacted by bacterial community and physicochemical parameters. Environ Sci Pollut Res Int. (2017) 24:23753-62. doi: 10.1007/s11356-017-0032-0
36. Qiao, M. Ying GG, Singer AC, Zhu YG. Review of antibiotic resistance in China and its environment. Environ Int. (2018) 110:160-72. doi: 10.1016/j.envint.2017.10.016
37. Mokracka J, Koczura R, Jablonska L, Kaznowski A. Phylogenetic groups, virulence genes and quinolone resistance of integron-bearing Escherichia coli strains isolated from a wastewater treatment plant. Antonie Van Leeuwenhoek (2011) 99:817-24. doi: 10.1007/s10482-011-9555-4
38. Skovbjerg H, Norén O, Anthonsen D, Moller J, Sjöström H. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease. Scand J Gastroenterol. (2002) 37:812-7
39. Cui Li Du G, Zhang D, Chen J. Thermal stability and conformational changes of transglutaminase froma newly isolated Streptomyces hygroscopicus. Bioresour Technol. (2008) 99:3794-800. doi: 10.1016/j.biortech.2007.07.017
40. Harnett J, Myers SP, Rolfe M. Significantly higher faecal counts of the yeasts candida and saccharomyces identified in people with coeliac disease. Gut Pathog. (2017) 9:26. doi: 10.1186/s13099-017-0173-1
41. Ashorn S, Raukola H, Välineva T, Ashorn M, Wei B, Braun J, et al. Elevated serumanti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol. (2008) 28:486-94. doi: 10.1007/s10875-008-9200-9
42. IranzoM, Aguado C, Pallotti C, Cañizares JV,Mormeneo S. Transglutaminase activity is involved in Saccharomyces cerevisiae wall construction. Microbiol. (2002) 148:1329-34. doi: 10.1099/00221287-148-5-1329
43. Ruiz-Herrera J, Iranzo M, Elorza MV, Sentandreu R, Mormeneo S. Involvement of transglutaminase in the formation of covalent cross-links in the cell wall of Candida albicans. Arch Microbiol. (1995) 164:186-93. doi: 10.1007/BF02529970
44. Nieuwenhuizen WF, Pieters RH, Knippels LM, Jansen MC, Koppelman SJ. Is Candida albicans a trigger in the onset of coeliac disease? Lancet (2003) 361:2152-4. doi: 10.1016/S0140-6736(03)13695-1
45. Corouge M, Loridant S, Fradin C, Salleron J, Damiens S, Moragues MD, Souplet, V, et al. Humoral immunity links Candida albicans infection and celiac disease. PLoS ONE (2015) 10:e0121776. doi: 10.1371/journal.pone.0121776
46. Matthias T, Jeremias P, Neidhöfer S, Lerner A. The industrial food additive microbial transglutaminase, mimics the tissue transglutaminase and is immunogenic in celiac disease patients. Autoimm Rev. (2016) 15:1111-9. doi: 10.1016/j.autrev.2016.09.011
47. Rao RU, Mehta K. Transglutaminases, thioredoxins and protein disulphide isomerase: diverse enzymes with a common goal of cross-linking proteins in lower organisms. Indian J Exp Biol. (2004) 42:235-43
48. Tagami U, Shimba N, Nakaamura M, Yokoyama K, Suzuki E, Hirokawa T. Substrate specificity of microbial transglutaminase as revealed by threedimentional docking simulation and mutagenesis. Protein Eng Des Sel. (2009) 22:747-52. doi: 10.1093/protein/gzp061
49. Fittipaldi N, Segura M, Grenier D, Gottschalk M. Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Fut Microbiol. (2012) 7:259-79. doi: 10.2217/fmb.11.149
50. Xu B, Zhang P, Li W, Liu R, Tang J, Fan H. hsdS, Belonging to the type i restriction-modification system, contributes to the Streptococcus suis serotype 2 survival ability in phagocytes. Front Microbiol. (2017) 8:1524. doi: 10.3389/fmicb.2017.01524
51. Lebreton C, Menard S, Abed J, Moura IC, Coppo R, Dugave C, et al. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterol (2012) 143:698-707. doi: 10.1053/j.gastro.2012.05.051
52. Stricker S, de Laffolie J, Rudloff S, Komorowski L, Zimmer KP. Intracellular localization of microbial transglutaminase and its influence on the transport of gliadin in enterocytes. J Pediatr Gastroenterol Nutr. doi: 10.1097/MPG.0000000000002171
53. El Asmar R, Panigrahi P, Bamford P, Berti I, Not T, Coppa GV, et al. Hostdependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterol (2002) 123:1607-15. doi: 10.1053/gast.2002.36578
54. Hollon J, Puppa EL, Greenwald B, Goldberg E, Guerrerio A, Fasano A. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients (2015) 7:1565-76. doi: 10.3390/nu7031565
55. Terman JR, Kashina A. Post-translational modification and regulation of actin. Curr Opin Cell Biol. (2013) 25:30-8. doi: 10.1016/j.ceb.2012.10.009
56. Hiiragi T, Sasaki H, Nagafuchi A, Sabe H, Shen SC, Matsuki M, et al. Transglutaminase type 1 and its cross-linking activity are concentrated at adherens junctions in simple epithelial cells. J Biol Chem. (1999) 274:34148-54 doi: 10.1074/jbc.274.48.34148
57. Kaufmann A, Koppel R, Widmer M. Determination of microbial transglutaminase in meat and meat products. Food Addit Contam Part A Chem Anal Control, Exp Risk Assess. (2012) 29:1364-73. doi: 10.1080/19440049.2012.691557
58. Lerner A, Matthias T. Food industrial microbial transglutaminase in celiac disease: treat or trick. Int J Celiac Dis. (2015) 3:1-6. doi: 10.12691/ijcd-3-1-10
59. Cabrera-Cha'vez F, Rouzaud-Sa'ndez O, Sotelo-Cruz N, Calderón de la Barca AM. Bovine milk caseins and transglutaminase-treated cereal prolamines are differentially recognized by IgA of celiac disease patients according to age. J Agric Food Chem. (2009) 57:3754-9. doi: 10.1021/jf802596g
60. Elli L, Roncoroni L, Hils M, Pasternack R, Barisani D, Terrani C, et al. Immunological effects of transglutaminase-treated gluten in coeliac disease. Hum Immunol. (2012) 73:992-7. doi: 10.1016/j.humimm.2012.07.318
61. Falini ML, Elli L, Caramanico R, Bardella MT, Terrani C, Roncoroni L, et al. Immunoreactivity of antibodies against transglutaminasedeamidated gliadins in adult celiac disease. Dig Dis Sci. (2008) 53:2697-701. doi: 10.1007/s10620-007-0191-9
62. Cabrera-Cha'vez F, Rouzaud-Sa'ndez O, Sotelo-Cruz N, Calderón de la Barca AM. Transglutaminase treatment of wheat and maize prolamines of bread increase the serum IgA reactivity of celiac disease patients. J Agric Food Chem. (2008) 56:1387-91. doi: 10.1021/jf0724163
63. Berti C, Roncoroni L, Falini ML, Caramanico R, Dolfini E, Bardella MT, et al. Celiac-related properties of chemically and enzymatically modified gluten proteins. J Agric Food Chem. (2007) 55:2482-8. doi: 10.1021/jf062623n
64. Heredia-Sandoval NG, Islas-Rubio AR, Cabrera-Chávez F, Calderón de la Barca AM. Transamidation of gluten proteins during the bread-making process of wheat flour to produce breads with less immunoreactive gluten. Food Funct. (2014) 5:1813-8. doi: 10.1039/c4fo00118d
65. Ruh T, Ohsam J, Pasternack R, Yokoyama K, Kumazawa Y, Hils M. Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients' sera. J Agric Food Chem. (2014) 62:7604-11. doi: 10.1021/jf501275c
66. Dekking EHA, Van Veelen PA, de Ru A, Kooy-Winkelaara EMC, Gröneveld T, Nieuwenhuizen WF, Koning F. Microbial transglutaminase generate Tcell stimulatory epitopes involved in celiac disease. J Cereal Sci. (2008) 47:339-46. doi: 10.1016/j.jcs.2007.05.004
67. Gerrard JA, Sutton KH. Addition of transglutaminase to cereal products may generate the epitope responsible for coeliac disease. Trend Food Sci Technol. (2005) 16:510-2. doi: 10.1016/j.tifs.2005.07.002
68. Cottam JRA, Gerrard JA, (2012). Protein cross-linking in food-structure, applications, implications for health and food safety. In: Hui YH, editors. Food Biochemistry and Food Processing, 2nd ed. (Ames, IA: Blackwell), p. 207-23
69. Eidgeno ssische Departement des Innern (EDI). Verordnung des EDI u ber Lebensmittel tierischer Herkunft [in German]. [Regulation of the EDI about foods of animal origin. SR 817.022.108. Approved November 23 2005]. Available online at: https://www.admin.ch/opc/de/classified-compilation/20050164/index.html. (Accessed November 23, 2005)